Clinical Trial Update: CGM/Clarity Use, Glycemic Control and Clinical Outcomes [NA]

View source ↗

Summary

A University of Maryland-sponsored clinical trial evaluating CGM/Clarity use and glycemic outcomes in diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Diabetes Mellitus, Hyperglycemia | NA | Status: WITHDRAWN